LABORATORIO FARMAC.ERFO Cash Flow Reinvestment Rate
LABORATORIO FARMAC.ERFO cash flow reinvestment rate. LABORATORIO FARMAC.ERFO (RK7) has a Cash Flow Reinvestment Rate of 1.38x as of December 2023, reinvesting €1.79 Million (capex €1.45 Million plus investments €345.57K) from operating cash flow of €1.30 Million. Explore RK7 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of LABORATORIO FARMAC.ERFO (2021–2023)
Cash flow reinvestment rate of LABORATORIO FARMAC.ERFO from 2021 to 2023. Historical reinvestment intensity for LABORATORIO FARMAC.ERFO across 3 annual periods. Explore LABORATORIO FARMAC.ERFO capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
LABORATORIO FARMAC.ERFO Cash Flow Reinvestment Rate by Year (2021–2023)
LABORATORIO FARMAC.ERFO cash flow reinvestment rate by year from 2021 to 2023. Year-by-year capital reinvestment analysis for LABORATORIO FARMAC.ERFO. For the full cash flow conversion analysis, see LABORATORIO FARMAC.ERFO cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.38x | €1.79 Million | €1.30 Million | €1.45 Million | ▼ -44.4% |
| 2022 | 2.49x | €1.89 Million | €761.80K | €1.18 Million | ▲ +806.2% |
| 2021 | 0.27x | €623.55K | €2.27 Million | €242.84K | — |